Second-line chemotherapy after disease progression following first-line FOLFOXIRI in advanced pancreatic cancer patients

被引：0
|
作者：
Vasile, E. [1 ]
Vivaldi, C. [1 ]
Fornaro, L. [1 ]
Caparello, C. [1 ]
Musettini, G. [1 ]
Pasquini, G. [1 ]
Catanese, S. [1 ]
Lencioni, M. [1 ]
Ricci, S. [1 ]
Falcone, A. [1 ]
机构：
[1] AOU Pisana, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
L26
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [41] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [42] Second-line chemotherapy in advanced bladder cancer
    Pavone-Macaluso, M
    Sternberg, C
    UROLOGIA INTERNATIONALIS, 2000, 64 (02) : 61 - 69
  • [43] Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer
    Sadaka, Shiori
    Iwashita, Takuji
    Fujii, Hironori
    Kato-Hayashi, Hiroko
    Ohata, Koichi
    Uemura, Shinya
    Shimizu, Masahito
    Suzuki, Akio
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [44] REINTRODUCTION OF FOLFOXIRI TREATMENT IN METASTATIC COLORECTAL CANCER PATIENTS PROGRESSED AFTER FIRST-LINE FOLFOXIRI
    Baldi, Giacomo Giulio
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Stasi, Irene
    Salvatore, Lisa
    Fornaro, Lorenzo
    Cupini, Samanta
    Pfanner, Elisabetta
    Brunetti, Isa Maura
    Di Donato, Samantha
    Caponi, Sara
    Allegrini, Giacomo
    Antonuzzo, Andrea
    Ricci, Sergio
    Andreuccetti, Michele
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2009, 20
  • [45] Prognostic factors for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer
    Herrmann, C.
    Abel, U.
    Stremmel, W.
    Jaeger, D.
    Herrmann, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy containing paclitaxel for advanced gastric cancer.
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Makino, Yoshinori
    Sekiguchi, Masatoshi
    Ishizone, Yoshimasa
    Boku, Narikazu
    Yamaguchi, Masakazu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [47] Reintroduction of FOLFOXIRI treatment in metastatic colorectal cancer patients progressed after first-line FOLFOXIRI
    Vasile, E.
    Masi, G.
    Loupakis, F.
    Cupini, S.
    Baldi, G. G.
    Salvatore, L.
    Fornaro, L.
    Pfanner, E.
    Ricci, S.
    Falcone, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 346 - 346
  • [48] Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis
    Akiyoshi Kasuga
    Yasuo Hamamoto
    Ayano Takeuchi
    Naohiro Okano
    Kazuhiro Togasaki
    Yu Aoki
    Takeshi Suzuki
    Kenta Kawasaki
    Kenro Hirata
    Yasutaka Sukawa
    Takanori Kanai
    Hiromasa Takaishi
    Investigational New Drugs, 2018, 36 : 939 - 948
  • [49] Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis
    Kasuga, Akiyoshi
    Hamamoto, Yasuo
    Takeuchi, Ayano
    Okano, Naohiro
    Togasaki, Kazuhiro
    Aoki, Yu
    Suzuki, Takeshi
    Kawasaki, Kenta
    Hirata, Kenro
    Sukawa, Yasutaka
    Kanai, Takanori
    Takaishi, Hiromasa
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 939 - 948
  • [50] Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers
    Patil, V
    Karpe, A.
    Noronha, V
    Joshi, A.
    Muddu, V
    Bhattacharjee, A.
    Dhumal, S.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 629 - 631
12345